Anti-Polyserase-2 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the Serase-1 domain of human Polyserase-2, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Monkey, Dog
UniProt
Q5K4E3
Size
100ug
Cat. #
RP1Polyserase2

In stock

SKU
RP-Polyserase2

Options

As low as: $130.00

Target Overview

Polyserase-2 (gene name PRSS36, UniProt Q5K4E3) is a secreted serine protease (EC 3.4.21.-) localized to the extracellular matrix. The 855-amino acid protein exhibits trypsin-like specificity, hydrolyzing peptide substrates including N-t-Boc-Gln-Ala-Arg-AMC and N-t-Boc-Gln-Gly-Arg-AMC with a marked preference for arginine over lysine at the P1 position. Polyserase-2 belongs to the polyserine protease family, a group of multidomain serine proteases characterized by tandem protease domains. While the full physiological substrate repertoire remains under investigation, the enzyme's extracellular localization and substrate specificity suggest roles in extracellular matrix remodeling or signaling peptide processing. Recent genomic studies have implicated PRSS36 as a potential druggable target in autoimmune conditions including psoriasis and myasthenia gravis, based on Mendelian randomization analyses linking genetic variation at this locus to disease risk. Four rabbit polyclonal antibodies targeting the Serase-1 domain are available from Triple Point Biologics, validated for Western blot applications in human samples.

Background

Serine proteases constitute one of the largest enzyme families in mammalian genomes, participating in diverse physiological processes from digestion to blood coagulation and immune responses. Polyserase-2 is distinguished by its multidomain architecture, though functional characterization of individual domains remains incomplete. The protein is secreted into the extracellular space, where it may process bioactive peptides or remodel matrix components. Substrate profiling with fluorogenic peptides demonstrates clear preference for Arg-based substrates, consistent with trypsin-like activity, though the endogenous protein or peptide targets have not been definitively identified. Recent human genetic studies have drawn attention to PRSS36 as a candidate therapeutic target. Guo et al. (2024) applied Mendelian randomization to prioritize drug targets for psoriasis, identifying PRSS36 alongside TYK2 as genetically supported candidates. In parallel, two independent studies examined myasthenia gravis using integrative genomic approaches: Ouyang et al. (2024) used colocalization analysis to link PRSS36 variants to disease risk, while Li et al. (2024) conducted multi-omics profiling that implicated the gene in immune cell-specific mechanisms. These findings position Polyserase-2 within immune-related pathways, though the mechanistic connection between protease activity and autoimmune pathology requires experimental validation. Beyond immune contexts, Wang et al. (2021) reported PRSS36 among genes with somatic alterations in pseudomyxoma peritonei, a rare peritoneal malignancy, suggesting potential involvement in tumor biology. Experimental tools for studying Polyserase-2 have been limited. The availability of domain-specific antibodies validated for multiple applications enables researchers to examine protein expression patterns across tissues and disease states, assess post-translational regulation, and investigate localization within the extracellular matrix compartment.

References

  1. Guo X et al (2024) Validation of TYK2 and exploration of PRSS36 as drug targets for psoriasis using Mendelian randomization. Sci Rep. PubMed · DOI
  2. Ouyang Y et al (2024) Mendelian randomization and colocalization analysis reveal novel drug targets for myasthenia gravis. Hum Genomics. PubMed · DOI
  3. Li J et al (2024) Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis. J Transl Med. PubMed · DOI
  4. Wang B et al (2021) The mutational landscape and prognostic indicators of pseudomyxoma peritonei originating from the ovary. Int J Cancer. PubMed · DOI

Additional Specifications

Gene Symbol PRSS36
UniProt ID Q5K4E3
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Monkey, Dog
Pack Size 100ug
Immunogen (Serase-1 domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 48-270.
Immunogen (carboxy end Serase-1 domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 805-855.
Immunogen (Serase-2 domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 310-540.
Immunogen (Serase-3 domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 570-820.
Alternate Names PRSS36, Polyserine protease 2, Serine protease 36, EC 3.4.21.-

Frequently Asked Questions

What is the expected molecular weight for Polyserase-2 on Western blot?

Full-length Polyserase-2 (PRSS36, UniProt Q5K4E3) contains 855 amino acids and migrates at approximately 95 kDa on reducing SDS-PAGE gels. The calculated molecular weight is slightly lower, but glycosylation at predicted N-linked sites typically shifts the apparent size upward. Because Polyserase-2 is a secreted protease localized to the extracellular matrix, conditioned medium or ECM-enriched fractions often yield cleaner bands than whole-cell lysates. If you observe lower molecular weight bands, consider the possibility of proteolytic processing or activation cleavage, which is common among serine proteases with zymogen precursors.

What dilution should I start with for Western blot with this Polyserase-2 antibody?

We recommend starting at 1:1000 dilution for Western blot, which has been validated in human lysates and conditioned media. Optimal dilution may vary depending on Polyserase-2 expression level in your sample and the sensitivity of your detection system. If you are working with low-abundance samples or serum-free conditioned medium, consider concentrating your sample or using a 1:500 dilution. For IHC applications, a range of 1:100 to 1:500 is typical, though you should titre the antibody against positive-control tissue sections. Always include a no-primary control to assess nonspecific background.

Is this Polyserase-2 antibody validated in mouse and rat samples?

This rabbit polyclonal antibody is validated for human Polyserase-2. Cross-reactivity with mouse, rat, monkey, and dog orthologs is predicted based on sequence homology but has not been experimentally confirmed. Human and mouse PRSS36 share approximately 70 percent amino acid identity, suggesting the antibody may recognize murine Polyserase-2, but we recommend pilot experiments at multiple dilutions to confirm signal specificity. Include a blocking peptide control or PRSS36 knockdown lysate if available. If you observe bands at unexpected molecular weights, verify by mass spectrometry or orthogonal detection methods to rule out off-target binding.

What sample preparation works best for detecting secreted Polyserase-2?

Because Polyserase-2 is a secreted serine protease localized to the extracellular matrix, conditioned culture medium and ECM-enriched fractions are the most productive sample types. If working with conditioned medium, concentrate 10- to 50-fold using centrifugal filters (10 kDa cutoff) to improve signal. For tissue lysates, include protease inhibitors targeting serine proteases (AEBSF or PMSF) during homogenization to prevent autocatalytic degradation. Avoid boiling samples for extended periods, as aggregation can occur. Load 20 to 50 micrograms of total protein per lane for Western blot, and optimize lysis buffer composition if background is high.

Does Polyserase-2 have isoforms or splice variants I should know about?

PRSS36 encodes a single predominant transcript corresponding to the 855-amino acid full-length protein. Alternative splicing has not been extensively documented in public databases, though low-abundance variants cannot be ruled out in specific tissues. The defining feature of Polyserase-2 is its membership in the polyserine protease family, characterized by tandem protease domains within a single polypeptide. On Western blot, you may observe doublets or ladder patterns if the protease undergoes activation cleavage or limited proteolysis. These processing events are consistent with serine protease biology and do not necessarily indicate isoform diversity. Consult tissue-specific transcriptome data if working with specialized cell types.

What positive control tissues or cell lines should I use for Polyserase-2?

Polyserase-2 expression is tissue-restricted, and public expression databases show variable detection across cell types. If you are establishing the assay for the first time, prioritize human cell lines or tissues where PRSS36 mRNA is detectable by RNA-seq or qPCR. Conditioned medium from overexpressing cell lines or recombinant Polyserase-2 protein can serve as a positive control for Western blot optimization. Because the physiological substrate repertoire and expression pattern remain under active investigation, empirical screening may be necessary. Include matched negative controls, such as PRSS36-knockout or siRNA-depleted lysates, to confirm antibody specificity and avoid misinterpretation of nonspecific bands.

How should I store this Polyserase-2 antibody and what is the shelf life?

Store the antibody at –20 degrees Celsius in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase aggregation. The 100-microgram pack size is sufficient for approximately 100 Western blots at 1:1000 dilution. Once thawed, an aliquot can be kept at 4 degrees Celsius for up to one month if supplemented with 0.02 to 0.05 percent sodium azide as a preservative. Avoid prolonged storage in frost-free freezers, which cycle temperature. Rabbit polyclonal antibodies typically retain activity for two to three years when stored under these conditions. If you observe declining signal or increased background over time, prepare a fresh aliquot.

Can I use this antibody for immunoprecipitation or pull-down of Polyserase-2?

This rabbit polyclonal antibody is validated for Western blot, but immunoprecipitation performance has not been formally tested. Polyclonal antibodies often work well for IP because they recognize multiple epitopes, increasing capture efficiency. If you plan to immunoprecipitate Polyserase-2 from conditioned medium or cell lysates, start with 2 to 5 micrograms of antibody per 500 micrograms to 1 milligram of total protein. Use Protein A or Protein G agarose beads suitable for rabbit IgG. Include protease inhibitors throughout to prevent autocatalytic degradation, as Polyserase-2 is an active serine protease. Verify enrichment by Western blot and consider a parallel IgG control to assess nonspecific binding.

Western blot validation for RP-Polyserase2 — 4 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

Polyserase-2: Serase-1 domain — WB validation
WB · Panel 1 Polyserase-2: Serase-1 domain
Polyserase-2: carboxy end Serase-1 domain — WB validation
WB · Panel 2 Polyserase-2: carboxy end Serase-1 domain
Polyserase-2: Serase-2 domain — WB validation
WB · Panel 3 Polyserase-2: Serase-2 domain
Polyserase-2: Serase-3 domain — WB validation
WB · Panel 4 Polyserase-2: Serase-3 domain

Custom validation studies available on request — contact us.

Also known as:

  • PRSS36
  • Polyserine protease 2
  • Serine protease 36
  • EC 3.4.21.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →